Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Mar 12, 2009

34519_dirs_2009-03-12_6e70c925-a24a-49e8-9132-071e0a05b394.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-03-10

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-03-10 Common stock, par value $0.10 per share P 200 $2.00 Acquired 437327 Direct
2009-03-10 Common stock, par value $0.10 per share P 1000 $1.9981 Acquired 438327 Direct
2009-03-11 Common stock, par value $0.10 per share P 99 $1.76 Acquired 438426 Direct
2009-03-12 Common stock, par value $0.10 per share P 876 $1.7499 Acquired 439302 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes 185,073 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.